Source comparison
Healing & Recovery Peptides Compared: Research Application Comparison
The following table compares healing and recovery peptides across mechanism, half-life, ideal research model, dosing frequency, and practical assessment. BPC-157 VEGF receptor activation, NO pathway modulation, localized angiogenesis ~4 hours systemic; extende
This comparison does not assign a generated winner or score.
- The following table compares healing and recovery peptides across mechanism, half-life, ideal research model, dosing frequency, and practical assessment.
- BPC-157
- VEGF receptor activation, NO pathway modulation, localized angiogenesis
- ~4 hours systemic; extended tissue residence
- Gastrointestinal mucosa repair, tendon/ligament injury, localized soft tissue damage
- Once or twice daily, 200–500 mcg per injection
- Best for localized injury models requiring rapid fibroblast migration and vascular support—short half-life limits systemic applications
- TB-500
- Actin-binding protein, promotes cell migration, systemic angiogenesis
- ~10 days
- Muscle regeneration, cardiac ischemia models, systemic wound healing, stroke recovery
- Once or twice weekly, 2–10 mg per injection
- Ideal for systemic tissue repair across multiple injury sites—long half-life reduces dosing frequency and handling stress in multi-week studies
- GHK-Cu
- Copper-dependent collagen/elastin synthesis, MMP regulation, TGF-β signaling
- Several hours to 1 day (copper dissociation-dependent)
- Dermal wound healing, photoaging models, chronic wound repair, tissue remodeling
- 2–3 times weekly (subcutaneous), daily (topical), 1–3 mg per injection
- Best for structural protein synthesis and extracellular matrix remodeling—less effective for acute injury but superior for chronic tissue degradation models